Not Yet Recruiting OBSERVATIONAL NCT07285408

Sarcopenia and NMIBC Prognosis Study (SARC-NMIBC)

Impact of Body Composition, Sarcopenia, Myosteatosis, and Nutritional Status on Recurrence and Progression in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Observational Study

Sponsor: General Hospital Sveti Duh

Conditions Bladder Cancer Cell Transitional

Updated 1 time since 2026 Last updated: Dec 12, 2025 Started: Mar 2, 2026 Primary completion: Jul 12, 2027 Completion: Jul 9, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bladder Cancer Cell Transitional, this trial is actively recruiting participants. The trial is conducted by General Hospital Sveti Duh and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital Sveti Duh

Data source: General Hospital Sveti Duh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.